Literature DB >> 6175194

A new screen for anti-inflammatory agents. Estimation of rat serum acute phase alpha2-macroglobulin levels using an electroimmunoassay.

B A Baldo, S C Chow, C Euers.   

Abstract

Induction of alpha2-macroglobulin acute phase protein in rats by the injection of turpentine revealed strain and sex differences in the amounts of this protein detected in sera by rocket immunoelectrophoresis. Studies in vivo with a wide variety of drugs showed that non-steroidal anti-inflammatory drugs (NSAID) such as aspirin, indomethacin and BW 755C as well as colchicine, clofibrate and clozic, inhibited serum concentrations of the acute phase protein 48 h after turpentine injection. The procedure used offers a new and convenient screen for assessing NSAIDs and the method may be of value as a screen for new clozic-like compounds with anti-rheumatic activity. The possibility that the NSAIDs are inhibiting a humoral factor initiated by the inflammatory stimulus and that the humoral factor is a metabolite of arachidonic acid is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6175194     DOI: 10.1007/BF02004710

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  29 in total

1.  SERUM PROTEIN CHANGES IN RATS WITH ARTHRITIS INDUCED BY MYCOBACTERIAL ADJUVANT.

Authors:  J S LOWE
Journal:  Biochem Pharmacol       Date:  1964-04       Impact factor: 5.858

2.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

3.  Adjuvant disease in rats: biochemical criteria for distinguishing several phases of inflammation and arthritis.

Authors:  W A Baumgartner; F W Beck; A Lorber; C M Pearson; M W Whitehouse
Journal:  Proc Soc Exp Biol Med       Date:  1974-02

4.  2 -acute phase globulin in rat serum. Purification, determination and interaction with trypsin.

Authors:  K Ganrot
Journal:  Biochim Biophys Acta       Date:  1973-01-25

5.  Glycoprotein synthesis and steroids. I. Relationship of trauma, cortisol administration and alpha-2-GP synthesis.

Authors:  A E Bogden; J H Gray
Journal:  Endocrinology       Date:  1968-06       Impact factor: 4.736

6.  Immunochemical detection of an acute-phase protein in rat serum.

Authors:  H E Weimer; D C Benjamin
Journal:  Am J Physiol       Date:  1965-10

7.  A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.

Authors:  M Aylward; J Maddock; R Wheeldon; R J Parker
Journal:  Rheumatol Rehabil       Date:  1975-05

8.  Differential effect of clofibrate on inflammation-induced alterations in plasma proteins in the rat.

Authors:  M C Powanda; F B Abeles; K A Bostian; J P Fowler; E C Hauer
Journal:  Biochem J       Date:  1979-03-15       Impact factor: 3.857

9.  The alpha macroglobulins of rat serum.

Authors:  A H Gordon
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

10.  Rheumatoid arthritis: effects of a new agent (ICI 55 897) on serum acute phase proteins and the erythrocyte sedimentation rate.

Authors:  B McConkey; R S Amos; M E Billingham; T J Constable; R A Crockson; A P Crockson; P J Forster
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

View more
  4 in total

1.  Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin.

Authors:  B Joe; U J Rao; B R Lokesh
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

2.  Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin.

Authors:  N Hunter; K M Weston; N A Bowern
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

3.  Additional inhibitors of rat serum acute phase alpha 2-macroglobulin levels. Effect of 6-mercaptopurine and some lipoxygenase and cyclo-oxygenase inhibitors.

Authors:  B A Baldo
Journal:  Agents Actions       Date:  1982-07

4.  Inflammation, counter irritation and rat serum acute phase alpha 2-macroglobulin levels.

Authors:  B A Baldo
Journal:  Agents Actions       Date:  1982-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.